Clinical trial
Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung…
NCT00352950 · Amgen, Industry · Withdrawn
Key facts
| NCT number | NCT00352950 |
|---|---|
| Title | Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung Cancer |
| Official title | An Open-Label Clinical Trial Evaluating the Safety and Pharmacodynamics of Sirolimus and Panitumumab in Subjects With Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Amgen, Industry |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Oncology, Non-Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | AMG 954/Panitumumab |
| Enrollment | 0 |
| Start date | Mar 1, 2006 |
| Completion | Feb 1, 2008 |
| First posted | Jul 17, 2006 |
| Last update posted | Sep 6, 2018 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: